Suhayl Dhib-Jalbut Selected Research

Suhayl Dhib-Jalbut Research Topics

Disease

29	Multiple Sclerosis 02/2022 - 04/2002
6	Relapsing-Remitting Multiple Sclerosis 02/2021 - 04/2007
4	Inflammation (Inflammations) 12/2020 - 06/2005
4	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 05/2003
3	Demyelinating Diseases (Demyelinating Disease) 02/2021 - 05/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2014 - 05/2003
3	Disease Progression 01/2014 - 03/2011
2	Hypophosphatemia 02/2022 - 02/2021
2	Infections 01/2021 - 01/2016
2	Neuroinflammatory Diseases 08/2020 - 08/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 10/2016 - 07/2006
1	Leukopenia 02/2022
1	COVID-19 01/2021
1	Stroke (Strokes) 08/2020
1	Dysbiosis 10/2017
1	Menstruation Disturbances 01/2016
1	Virus Diseases (Viral Diseases) 12/2013
1	Neuromyelitis Optica (Devic's Disease) 06/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2009
1	Amyloid Plaque 07/2006
1	Tetanus 07/2003
1	Atrophy 05/2003
1	Nervous System Diseases (Neurological Disorders) 07/2002
1	Central Nervous System Diseases (CNS Diseases) 07/2002
1	Brain Neoplasms (Brain Tumor) 07/2002
1	Viral Encephalitis 07/2002
1	Autoimmune Diseases of the Nervous System 04/2002

Drug/Important Bio-Agent (IBA)

10	Glatiramer Acetate (Copaxone)FDA Link 07/2021 - 04/2002
7	CytokinesIBA 10/2016 - 07/2003
7	Interferon-betaIBA 08/2014 - 07/2002
5	GadoliniumIBA 02/2022 - 05/2003
4	Biomarkers (Surrogate Marker)IBA 08/2014 - 06/2011
4	InterferonsIBA 12/2013 - 04/2002
3	Interferon beta-1b (Betaseron)FDA Link 10/2020 - 01/2012
3	AntigensIBA 01/2014 - 07/2003
2	Gadolinium DTPA (Magnevist)FDA Link 02/2022 - 02/2021
2	Complement C3 (C3 Complement)IBA 02/2021 - 10/2017
2	Dimethyl FumarateIBA 02/2021 - 01/2019
2	Myelin Basic ProteinIBA 12/2020 - 05/2003
2	AutoantigensIBA 10/2017 - 05/2003
2	Pharmaceutical PreparationsIBA 01/2017 - 05/2003
2	ChemokinesIBA 08/2014 - 09/2010
1	Phosphates (Orthophosphate)IBA 02/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	EpitopesIBA 12/2020
1	Dichlororibofuranosylbenzimidazole (DRB)IBA 12/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2020
1	FibrinIBA 08/2020
1	Fibrinogen (Factor I)FDA Link 08/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2017
1	AnaphylatoxinsIBA 10/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2017
1	Hormones (Hormone)IBA 01/2016
1	Estriol (Epiestriol)IBA 01/2016
1	Complement System Proteins (Complement)IBA 08/2014
1	Natalizumab (Tysabri)FDA Link 01/2014
1	Cell Adhesion MoleculesIBA 01/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2014
1	Monoclonal AntibodiesIBA 01/2014
1	HLA-DR Antigens (HLA-DR)IBA 10/2013
1	AntibodiesIBA 06/2011
1	Toll-Like Receptor 9IBA 12/2010
1	Chemokine ReceptorsIBA 09/2010
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2009
1	Nerve Growth Factors (Neurotrophins)IBA 05/2009
1	Proteins (Proteins, Gene)FDA Link 07/2006
1	Protein AggregatesIBA 07/2006
1	Therapeutic UsesIBA 11/2003
1	Peptides (Polypeptides)IBA 07/2003
1	Amino Acids FDA Link 05/2003
1	Complementary DNA (cDNA)IBA 07/2002

Therapy/Procedure

9	Therapeutics 01/2021 - 05/2003
1	Injections 01/2016
1	Immunomodulation 10/2013
1	Immunotherapy 04/2002